Drugpolitik: Trump’s pharma trade war puts medicines in the Brexit spotlight

Eighteen months into his Presidency, Donald Trump has finally found a saleable enemy for America’s high medical bills: ‘freeloading foreign governments.’ Healthcare costs often poll as one of the leading concerns of U.S. citizens, but Trump hasn’t been able to conjure a bogeyman who doesn’t infringe on the low-regulation, low-tax mantra of America First. UntilRead more

Brexit: The one year countdown begins. What do you need to be looking out for over the next 12 months?

It’s exactly one year until the UK officially leaves the EU. Many are saying we are further along than expected. The EU agreed to move onto phase two of the negotiations back in December, and this month we saw the UK secure a provisional deal on transition. But before we get too carried away, what’sRead more

Theresa May’s Brexit roadmap: What does it actually mean?

A hallmark of Theresa May’s government to date has been the creation of policy vacuums which allow others, usually her opponents, to shape the political narrative. In this context, today’s speech from the Prime Minister on Brexit was essential to regain the initiative – from those both in Europe and domestically who have a differentRead more

Can pharma get the right treatment? Brexit and the pharmaceutical industry

As Brexit draws closer, sectors are coming to terms with the implications of what separation may mean. The pharmaceutical industry was not one that attracted vast attention at the start of the negotiating process, with banking and farming taking up more column inches. However, as time has progressed the press, politicians and the sector itselfRead more

The EU Withdrawal Bill: To kill, or not to kill? That is the question…

Last week saw the highly contentious EU Withdrawal Bill pass from the House of Commons to the House of Lords in what was widely agreed to have been a smooth passage for the Bill. However, with its second reading set to take place early next week in one of the largest and most Europhilic parliamentaryRead more

Cautiously carrying on

With Conservative Party conference over, focus returns to Westminster, and to Brexit. And UK business leaders are becoming increasingly concerned. Stanford and Nottingham universities have teamed up over the past year, with the help of the Bank of England, to track the views of 2,500 chief executives and chief financial officers towards Brexit negotiations. TheyRead more